Grace Therapeutics, Inc. (GRCE) vs Sangamo Therapeutics, Inc. (SGMOQ)
- Grace Therapeutics, Inc. GRCE 1.89 −3.08%
- Sangamo Therapeutics, Inc. SGMOQ 0.11 −21.43%
Grace Therapeutics, Inc. and Sangamo Therapeutics, Inc. are both Biotechnology companies. Grace Therapeutics, Inc. and Sangamo Therapeutics, Inc. are of similar size ($41.9M and $41.0M). Grace Therapeutics, Inc. grew revenue faster over the last twelve months: 1,286.8% against −45.8%. Grace Therapeutics, Inc. has the higher net margin (0.00% vs −356.9%) and the lower return on invested capital (−43.4% vs 0.00%). Across the 16 metrics below, Grace Therapeutics, Inc. leads on 9 and Sangamo Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | GRCE | SGMOQ | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (357.55%) | 0.00% |
| Net margin | 0.00% | (356.89%) | 0.00% |
| Free cash flow margin | 0.00% | (261.76%) | 0.00% |
| Return on equity | (36.19%) | 1,755.72% | (56.36%) |
| Return on assets | (33.74%) | (168.79%) | (48.04%) |
| Return on invested capital | (43.36%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack